Home / Cancer and immune system
ATC group L
Cancer and immune system: medicine shortages
107 medicines in this group have a reported shortage somewhere in the five countries. The dots show which countries.
Products short587all countries
Medicines107active ingredients
In all 53countries
Share of all11%of products short
Subgroups
By country
Medicines
Sorted by number of countries affected.
Adalimumab Cyclophosphamide Oxaliplatin Abiraterone Bendamustine Capecitabine Carboplatin Doxorubicin Epirubicin Fingolimod Gemcitabine Ifosfamide Lenalidomide Tacrolimus Apremilast Bicalutamide Ciclosporin Cytarabine Docetaxel Exemestane Filgrastim Fluorouracil Fulvestrant Golimumab Idarubicin Imatinib Melphalan Mitomycin Pazopanib Pemetrexed Pirfenidone Plerixafor Sorafenib Topotecan Trabectedin Ustekinumab Vinflunine Anagrelide Anastrozole Axitinib Azacitidine Bcg Vaccine Binimetinib Bortezomib Bosutinib Carmustine Dimethyl Fumarate Encorafenib Erlotinib Etoposide Flutamide Hydroxycarbamide Infliximab Irinotecan Lapatinib Letrozole Leuprorelin Methotrexate Methotrexate Mycophenolic Acid Nintedanib Paclitaxel Pentostatin Rituximab Secukinumab Sunitinib Temozolomide Thiotepa Tocilizumab Triptorelin Vinblastine Vindesine Vinorelbine Aldesleukin Aminolevulinic Acid Asparaginase Azathioprine Basiliximab Bevacizumab Buserelin Busulfan Certolizumab Pegol Cisplatin Clofarabine Dacarbazine Dasatinib Eribulin Etanercept Everolimus Fludarabine Gefitinib Interferon Gamma Leflunomide Lipegfilgrastim Medroxyprogesterone Megestrol Mitoxantrone Nilotinib Nivolumab Pomalidomide Raltitrexed Spesolimab Tamoxifen Teriflunomide Trastuzumab Trifluridine, Combinations Trofosfamide